1. Studies were performed to investigate the metabolic fate of dipeptides when administered intravenously in rats. Glycyl-leucine, glycylglycine or glycylsarcosine was injected into the jugular vein. The plasma disappearance rate after the peak plasma concentrations was most rapid for glycyl-leucine and least rapid for glycylsarcosine. 2. During urine collection for 40 min, trace amounts of glycyl-leucine and glycylglycine and 13% of the injected glycylsarcosine were excreted. 3. Neither glycylglycine nor glycyl-leucine was detected in the liver, muscle, intestinal mucosa or renal cortex, but concentrations of glycine or leucine, or both, in these tissues were increased after each injection. In contrast, glycylsarcosine was recovered in all these tissues with concentrations in the renal cortex being far greater than in any other tissue, but sarcosine was found only in the renal cortex and intestinal mucosa. 4. The changes in plasma concentrations of free amino acids, glucose and glucagon, and tissue concentrations of free amino acids, were similar after the intravenous administration of glycyl-leucine and an equimolar mixture of free glycine and leucine. However, the amount of insulin secreted during the 40 min after glycyl-leucine injection was 1-6 times that produced after the injection of the corresponding amino acid mixture. 5. Results show that, within the present experimental conditions, the intravenous administration of dipeptides is as effective as that of the corresponding free amino acids in enriching the tissue pools of amino acids. It is suggested that efficient hydrolysis by cellular enzymes prohibits accumulation of intact dipeptides in body tissues.

Peptide hydrolase activities against glycyl-L-leucine and glycylglycine were investigated in the soluble fractions of blood, liver, kidney cortex, skeletal muscle (gastrocnemius), and jejunal and ileal mucosa of rats. The maximal hydrolase activity in each tissue was determined when the incubation conditions, such as time, pH, substrate and enzyme concentrations, and ionic requirements were optimal. The kinetic constants (apparent Km and Vmax) were determined from Lineweaver-Burk double reciprocal graphs. Maximal hydrolysis rates against both dipeptides were many times greater by kidney and intestinal segments than by those of muscle, liver, or blood. The order of Vmax for hydrolase activity against glycylleucine was kidney greater than ileum greater than jejunum greater than liver greater than muscle greater than blood, and the order against glycylglycine was ileum greater than kidney greater than jejunum greater than liver greater than muscle. Those tissues that had the lowest Vmax values (liver and muscle), when calculated on the basis of tissue weights, were shown to have activities comparable to the others. Results of this study are consistent with our previous findings that: 1) glycylleucine half-life in plasma is shorter than that of glycylglycine, and 2) disappearance rates of these dipeptides from plasma are not affected by nephrectomy or enterectomy.

No abstract

No abstract